These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 29753833

  • 1. Efficacy of a single dose of omalizumab for the prevention of ethylene oxide intraoperative anaphylaxis.
    Bilò MB, Corsi A, Brianzoni MF, Garritani MS, Antonicelli L.
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):249-250. PubMed ID: 29753833
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recurrent anaphylaxis during cardiac catheterization due to ethylene oxide.
    Hamad A, Iweala OI, Henderson C, Madan S, Stouffer GA, Commins SP, Kim EH.
    J Allergy Clin Immunol Pract; 2018 Aug; 6(6):2148-2150. PubMed ID: 29715563
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Persistent cow's milk anaphylaxis from early childhood monitored by IgE and BAT to cow's and human milk under therapy.
    Schocker F, Recke A, Kull S, Worm M, Jappe U.
    Pediatr Allergy Immunol; 2018 Mar; 29(2):210-214. PubMed ID: 29197130
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of Anaphylaxis Episodes in Idiopathic Anaphylaxis by Omalizumab.
    Košnik M, Zugan L, Rijavec M.
    Int Arch Allergy Immunol; 2024 Mar; 185(8):761-766. PubMed ID: 38527445
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Omalizumab, a savior in long term prevention of idiopathic anaphylaxis with urticaria: A case series.
    Singh GK.
    Dermatol Ther; 2021 Nov; 34(6):e15165. PubMed ID: 34676646
    [No Abstract] [Full Text] [Related]

  • 12. Aspirin tolerance in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease following treatment with omalizumab.
    Phillips-Angles E, Barranco P, Lluch-Bernal M, Dominguez-Ortega J, López-Carrasco V, Quirce S.
    J Allergy Clin Immunol Pract; 2017 Nov; 5(3):842-845. PubMed ID: 28117272
    [No Abstract] [Full Text] [Related]

  • 13. Omalizumab in idiopathic anaphylaxis.
    Warrier P, Casale TB.
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):257-8. PubMed ID: 19354075
    [No Abstract] [Full Text] [Related]

  • 14. Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.
    Broesby-Olsen S, Vestergaard H, Mortz CG, Jensen B, Havelund T, Hermann AP, Siebenhaar F, Møller MB, Kristensen TK, Bindslev-Jensen C, Mastocytosis Centre Odense University Hospital (MastOUH).
    Allergy; 2018 Jan; 73(1):230-238. PubMed ID: 28662309
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-IgE-assisted desensitization to egg and cow's milk in patients refractory to conventional oral immunotherapy.
    Martorell-Calatayud C, Michavila-Gómez A, Martorell-Aragonés A, Molini-Menchón N, Cerdá-Mir JC, Félix-Toledo R, De Las Marinas-Álvarez MD.
    Pediatr Allergy Immunol; 2016 Aug; 27(5):544-6. PubMed ID: 27003835
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.
    Dispenza MC, Bochner BS, MacGlashan DW.
    Front Immunol; 2020 Aug; 11():614402. PubMed ID: 33391286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.